Immuno Cure

Developer of DNA vaccines and immunotherapies for multiple disorders

placeSha Tin, Hong Kong, China calendar_todayFounded 2015 language immunocure.hk

Social engagement

Social engagement: 390 social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include AEF Greater Bay Area Fund.

Investor typeCountShare
Venture capital1100%

Recent activity

1 Aug 2025
Partnership
Greater Bay Area International Clinical Trial Institute of Hong Kong (GBAICTI) and Great Bay Area International Clinical Trials Centre of Shenzhen (BAY TRIAL)
Coming soon